| Tyrosine Kinase Inhibitors |
| Imatinib* |
| Sunitinib* |
| Regorafenib* |
| Nilotinib* |
| Sorafenib* |
| Masitinib |
| Vatalanib |
| Dovitinib |
| Pazopanib* |
| Cedarinib |
| Crenolanib |
| Hsp90 Inhibitors |
| BIIB021 |
| AT13387 |
| AUY922 |
| Ganestespib (STA-9090) |
| PI3K–AKT-mTOR inhibitors |
| Perifosine |
| Everolimus* |
| Sirolimus* |
| Temsirolimus* |
| Monoclonal Antibodies |
| Olaratumab |
| Insulin-like growth factor 1 receptor inhibitors. |
| OSI-906 (Linsitinib) |
Commercially available